2010
DOI: 10.1254/jphs.10119fp
|View full text |Cite
|
Sign up to set email alerts
|

A Synthetic Cell-Penetrating Peptide Antagonizing TrkA Function Suppresses Neuropathic Pain in Mice

Abstract: Abstract. Nerve growth factor (NGF) and its high-affinity receptor, TrkA, are one of the targets in the production of new drugs for the treatment of neuropathic pain. NGF contributes to both the initiation and maintenance of sensory abnormalities after peripheral nerve injury. This study examined the effects of IPTRK3, a new synthetic cell-penetrating peptide that antagonizes TrkA function, on neuropathic pain in mice. Partial sciatic nerve ligation (PSNL) was used to generate neuropathic pain, and we injected… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
12
0
1

Year Published

2011
2011
2022
2022

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 17 publications
(13 citation statements)
references
References 25 publications
0
12
0
1
Order By: Relevance
“…Gene expression of Ccl12 was significantly reduced at both 14 and 28 days post-exposure whereas only Il1β gene expression was significantly depressed at 28 days post-exposure. Ntrk1 , Kcnq3 and Oprd1 play important roles in neuropathic pain (Benbouzid et al, 2008; Dondio et al, 2001; Dost et al, 2004; Fritch et al, 2010; Ma et al, 2010; Shinoda et al, 2007; Ugolini et al, 2007) while Ccl12 , Tlr2 , and Il1β are involved in inflammation (Gundra et al, 2011; Mojsilovic-Petrovic et al, 2007; Niven et al, 2015; Oh et al, 2012; Yang et al, 2009). Ntrk1 also may be a part of a negative feedback loop linking neuropathic pain and inflammation.…”
Section: Discussionmentioning
confidence: 99%
“…Gene expression of Ccl12 was significantly reduced at both 14 and 28 days post-exposure whereas only Il1β gene expression was significantly depressed at 28 days post-exposure. Ntrk1 , Kcnq3 and Oprd1 play important roles in neuropathic pain (Benbouzid et al, 2008; Dondio et al, 2001; Dost et al, 2004; Fritch et al, 2010; Ma et al, 2010; Shinoda et al, 2007; Ugolini et al, 2007) while Ccl12 , Tlr2 , and Il1β are involved in inflammation (Gundra et al, 2011; Mojsilovic-Petrovic et al, 2007; Niven et al, 2015; Oh et al, 2012; Yang et al, 2009). Ntrk1 also may be a part of a negative feedback loop linking neuropathic pain and inflammation.…”
Section: Discussionmentioning
confidence: 99%
“… Anti-NGF blocking antibodies  TrkAd5 Watson et al, 2008;McNamee et al, 2010  Anti-TrkA blocking antibodies  TrkA antagonists Watson et al, 2008  Kinase inhibitors  Inhibitory peptides Martin et al, 2011;Ueda et al, 2010;Ma et al, 2010 Fig (1996). Basophil priming by neurotrophic factors.…”
Section: Trka Ngfmentioning
confidence: 99%
“…Such changes in anatomical and physiological properties of nociceptors may contribute to development of conditions such as autonomic dysreflexia (e.g., Marsh et al, 2002). TrkA antagonists prevent the sensitization (thermal and mechanical hyperalgesia) normally induced by partial nerve injury (Ma et al, 2010), and antagonism of TrkA signaling has been effective for controlling human pain (Mantyh et al, 2011). Hence, elevation in the levels of TrkA and NGF in response to contusive injury could play a role in some of the maladaptive processes after incomplete SCI.…”
Section: Discussionmentioning
confidence: 99%